CD274 and neoplasm: We hypothesized that combination with α-PD-L1 mAb blockade may result in increased presentation of tumor antigens to T cells and higher magnitude responses that may, therefore, avoid the observed escape of tumors from this treatment, as well as slow the overall growth of tumors to facilitate immune control.